Industry Analysis
Iluvatar CoreX’s stock surge reflects speculative overpricing of domestic GPGPU substitution narratives. Its technology stack remains incomplete: 3nm production relies on TSMC (Taiwan, China) for EUV, while U.S. export controls are tightening access to advanced packaging and EDA tools—posing severe supply chain risks. The 58.8x P/B ratio assumes >80% CAGR, yet losses are widening and customer concentration is high. NVIDIA could counter by accelerating H20-lite deployments across Hong Kong, China and Southeast Asia, eroding Iluvatar’s premium positioning. Without breakthroughs in chiplet interconnect or compute-in-memory architectures within 12–24 months, the valuation bubble may burst during earnings reality checks, triggering broader hard-tech sentiment correction.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.